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glitazone in reducing clinical events and plaque inﬂammatory burden
remains unknown. This study aims to determine whether pioglitazone
can reduce the number of plaque thrombosis incidences and whether
decreasing plaque inﬂammation is the mechanism by which piogli-
tazone reduces plaque thromboses.
METHODS Atherosclerotic rabbits were divided into two groups: the
atherosclerosis group (n¼13) and pioglitazone group (n ¼ 10). The
rabbits underwent pharmacological triggering to induce thrombosis.
Serum inﬂammatory markers, FDG uptake, macrophage and neovessel
staining detected arterial inﬂammation. PET/CT scans were performed
twice (baseline and post-treatment scans). Plaque area, macrophages,
and neovessels were measured and the histological sections were
matched with the PET/CT scans. Serum MMP-9 and hsCRP were lower
in the pioglitazone group compared to the atherosclerosis group.
RESULTS The SUVmean signiﬁcantly decreased in the pioglitazone
group (0.62  0.21 vs. 0.55  0.19, P ¼ 0.008), but increased in the
atherosclerosis group (0.61  0.15 vs. 0.91  0.20, P < 0.000). The
incidence rate of plaque rupture, plaque area, macrophage density,
and neovessels density was signiﬁcantly lower in rabbits with pio-
glitazone than without (15 % vs. 38 %, P < 0.001; 18.00  2.30 vs. 27.00
 1.60; P < 0.001; 8.80  3.94 vs. 28.26  2.49; P < 0.001; 16.50  3.09
vs. 29.00  2.11; P < 0.001, respectively). Moreover, plaque area and
macrophage density were positively correlated with SUV values.
CONCLUSIONS Our study suggests that pioglitazone can reduce the
number of plaque thrombosis incidences by decreasing plaque
inﬂammation. 18F-FDG-PET/CT can detect plaque inﬂammation and
assess the effects of antiatherosclerotic drugs.
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OBJECTIVES To investigate the inﬂuence of atorvastatin on IKK/NF-
lB Pathway of insulin resistance in vascular endothelial cells.
METHODS Human umbilical vein endothelial cells (HUVECs) were
cultured in vitro with high glucose and insulin to establish a model of
insulin resistance. Then the cells were treated with 10mmol/L of
atorvastatin for 24h. Western blot method were used to assay the
expression of pIKK, IkBa, NF-kB p65 protein. The levels of nitric oxide
(NO), endothelin-1 (ET-1), TNF-a, IL-6, ICAM-1 and VCAM-1 was
measured by enzyme linked immunosorbent assay (ELISA) kits.
RESULTS HUVECs were cultured with high glucose and insulin, the
levels of ET-1, TNF-a, IL-6, ICAM-1 and VCAM-1were increased, level
of NO decreased, p-IKK and NF-kB p65 expression was upregulated,
and IkBa expression was down-regulated (all P<0.05). Atorvastatin
reversed these changes (all P<0.05).
CONCLUSIONS Atorvastatin has the protective effect on insulin
resistance induced by high glucose in vascular endothelial cells. The
underlying mechanism may be connected with inhibition of IKK/NF-
lB Pathway.
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OBJECTIVES To investigate the effect and mechanism of Glucagon-
like peptide-1(GLP-1) on diabetic cardiomyopathy.
METHODS All rats were divided into normal group(N), diabetes
group(D, STZ and high fat diet to construct diabetic animal model),
diabetes treat with insulin group (DI) and diabetes treat with Exena-
tide (a glucagon-like peptide-1 receptor agonist) group (DA). After
modeling 12 weeks, we detected cardiac function by multimedia bio-
signal recorder, detected apoptosis rate of cardiomyocyte by TUNEL,
detected blood serum adiponectin by ELISA, detected protein
expression of PPARa, NF-kB by western-blotting.
RESULTS Compare with N group, the cardiac myocyte apoptosis rate of D
group was signiﬁcantly increased, the concentration of adiponectin was
signiﬁcantly decreased(P<0.05), the expression of PPARawas decreased
(P<0.05), the expression of NF-KB were signiﬁcantly increased, LV -dP/dtwas signiﬁcantly decreased, LVEDP was signiﬁcantly increased(P<0.05);
ComparewithDgroup, the apoptosis rate ofDAgroupcardiacmyocytewas
signiﬁcantly decreased(P<0.05), the concentration of adiponectin was
signiﬁcantly increased(P<0.05), the expression of PPARaand LV-dP/dt
were signiﬁcantly increased (P<0.05), LvEDP, the expression of NF-KB
were decreased (P<0.05). Compare with DA group, although the glucose
had no difference (P>0.05), the cardiacmyocyte apoptosis rate and LVEDP
of DI groupwere signiﬁcantly increased(P<0.05), the expression of PPARa
and LV-dP/dt were decreased (P<0.05), the expression of NF-KB was
signiﬁcantly increased, the concentration of adiponectin was signiﬁcantly
decreased(P<0.05).
CONCLUSIONS STZ plus high fat diet can induce diabetes, hypo-adi-
ponectin and lower expression of PPARa, which was contribute to
diabetic cardiomyocyte apoptosis and cardiomyopathy. After treated
with Exinatide, the concentration of plasma adiponectin was signiﬁ-
cantly higher, the expression of PPARa was signiﬁcantly increased,
the expression of NF-kB, and cardiac myocyte apoptosis rate were
decreased, cardiac function of diabetic cardiomyopathy rats was
improved, and this effect was independent with glucose.
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OBJECTIVES The aim of this study was to investigate the impact of
the coronary sinus (CS) and great cardiac vein (GCV) peripheral nerves
ablation on cardiac nerve sprouting and ventricular electrophysiology
after chronic MI in dogs.
METHODS Twenty-one anesthetized dogs were randomly divided
into the sham-operation (n ¼ 5), MI (n ¼ 8) and MI- denervation
groups (n ¼ 8), respectively. The dogs were ligated with left anterior
descending branch for MI induction, the CS and GCV peripheral
nerves were ablated by radiofrequency. 4 week after ablation or the
generation of MI, the incidence and duration of ventricular arrhyth-
mias (VA) were monitored for 1h during left stellate ganglion (LSG)
stimulation, and programmed electrical stimulation was performed to
measure the ventricular effective refractory period (ERP) and to
induce ventricular ﬁbrillation threshold (VFT) in all animals. At the
end of experiment, the density of tyrosine hydroxylase (TH) and
growth associated protein 43(GAP43)-positive sympathetic nerve ﬁ-
bers as well as infarct size were also detected. Systemic arterial
pressure and heart rate were monitored during experiment.
RESULTS 4 week after ablation or the generation of MI, two dogs in
only MI group died; the incidence and duration of VA in MI-ablation
group were signiﬁcantly lower than that MI-placebo group during LSG
stimulation (P<0.05), and sustained ventricular tachycardia was
induced in MI group. The infarcted border zone ERP and VFT in MI-
denervation groups were signiﬁcantly improved when compared with
MI group. Furthermore, the TH and GAP43-positive sympathetic
nerve ﬁbers in the cardiac base and infarcted border zone were also
decreased (P<0.05). Systemic arterial pressure and heart rate as well
as infarct size were displayed a marked difference when compared
with MI group (P>0.05).
CONCLUSIONS Using the canine MI model, we showed that local abla-
tion of CS and GCV peripheral nerves improves cardiac nerve sprouting
and ventricular electrophysiology after chronic MI, and reduces the
occurrence of VAwith no obvious effects on heart rate, systemic arterial
pressure and infarct size. Therefore, local cardiac denervation may pro-
tect from ventricular arrhythmias complicating chronic MI.
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OBJECTIVES To prove the effectiveness and feasibility of Luofengn-
ing-0 complexes and provide the experimental data for the prevention
of restenosis, we investigated the inhibitory effects of different ratio
